Methods for pretreating a subject with apoptotic cells
OwnerDavid L. Peritt, Gregory Harrimaninventors
Life of this patent
Estimating the term…
Loading patent…
OwnerDavid L. Peritt, Gregory Harrimaninventors
Estimating the term…
The present invention relates to methods for treating a subject predisposed to an autoimmune disease with extracorporeal photopheresis or an effective amount of apoptotic cells before the clinical manifestation of a symptom associated with the autoimmune disease. The present invention alsorelates to methods for treating a subject predisposed to an atopic disease with extracorporeal photopheresis or an effective amount of apoptotic cells before the clinical manitfestation of a symptom associated with the atopic disease. The present invention further relates to methods for treating a transplant donor and/or a transplant recipient, or an implant recipient with extracorporeal photopheresis or an effective amount of apoptotic cells prior to the transplant or implantation procedure.
A method comprising administering an effective amount of apoptotic cells to a subject predisposed to an autoimmune disease before the clinical manifestation of a symptom associated with said autoimmune disease.
A method comprising administering an effective amount of apoptotic cells to a subject predisposed to an atopic disease before the clinical manifestation of a symptom associated with said atopic disease
A method comprising administering an effective amount of apoptotic cells to a subject predisposed to an autoimmune reaction manifested by a T-cell response before the clinical manifestation of a symptom associated with said autoimmune reaction.
A method comprising administering an effective amount of apoptotic cells to a transplant donor prior to harvesting said transplant from said donor.
A method comprising administering an effective amount of apoptotic cells to a recipient of a transplant prior to said recipient receiving said transplant.
A method comprising administering an effective amount of apoptotic cells to a transplant donor prior to harvesting said transplant from said donor.
A method comprising administering an effective amount of apoptotic cells to a recipient of an implant prior to said recipient receiving said implant.
Dependencies are inferred from the claim text.